Model based analysis of hepatitis B vaccination strategies in the Netherlands

Vaccine

Volumn 27, Issue 8, 2009, Pages 1254-1260

  Kretzschmar, Mirjam ^a,b   Mangen, Marie Josee ^b   van de Laar, Marita ^c   de Wit, Ardine ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Hepatitis B; Mathematical model; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

AGE DISTRIBUTION; ARTICLE; CHILD CARE; CHRONIC HEPATITIS; ENDEMIC DISEASE; HEALTH CARE COST; HEALTH PROGRAM; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMIGRANT; MALE HOMOSEXUAL; MATHEMATICAL MODEL; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, THEORETICAL; NETHERLANDS; VACCINATION; YOUNG ADULT;

EID: 58749090523     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.009     Document Type: Article

References (34)

1. Zuckerman J., van Hattum J., Cafferkey M., Gjorup I., Hoel T., Rummukainen M.L., et al. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?. Lancet Infect Dis 7 6 (2007) 410-419
2. Hahne S., Ramsay M., and Coutinho R. Universal hepatitis B vaccination. Lancet Infect Dis 8 2 (2008) 87-88 author reply 90
3. Kretzschmar M., and de Wit A. Universal hepatitis B vaccination. Lancet Infect Dis 8 2 (2008) 85-87 author reply 90
4. de Wit GA, Kretzschmar M, Smits LJM, Struijs JN, Postma MJ, Laar MJWvd, et al. Kosten-effectiviteit van algemene vaccinatie tegen hepatitis B-(Interimrapportage). Bilthoven, The Netherlands: RIVM; 2000. Report no.: 403505004.
5. Kretzschmar M., de Wit G.A., Smits L.J., and van de Laar M.J. Vaccination against hepatitis B in low endemic countries. Epidemiol Infect 128 2 (2002) 229-244
6. Veldhuijzen I.K., Smits L.J., and van de Laar M.J. The importance of imported infections in maintaining hepatitis B in The Netherlands. Epidemiol Infect 133 1 (2005) 113-119
7. Marschall T., Kretzschmar M., Mangen M.J.J., and Schalm S. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur J Gastroenterol Hepatol 20 12 (2008) 1214-1225
8. Baaten G.G., Sonder G.J., Dukers N.H., Coutinho R.A., and Van den Hoek J.A. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol 79 12 (2007) 1802-1810
9. Hahne S.J., Veldhuijzen I.K., Smits L.J., Nagelkerke N., and van de Laar M.J. Hepatitis B virus transmission in The Netherlands: a population-based, hierarchical case-control study in a very low-incidence country. Epidemiol Infect 136 2 (2008) 184-195
10. Toy M., Veldhuijzen I.K., Mostert M.C., de Man R.A., and Richardus J.H. Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands. J Med Virol 80 3 (2008) 399-404
11. Koedijk F.D., Op de Coul E.L., Boot H.J., and van de Laar M.J. Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions. Ned Tijdschr Geneeskd 151 43 (2007) 2389-2394
12. van Steenbergen J.E., Niesters H.G., Op de Coul E.L., van Doornum G.J., Osterhaus A.D., Leentvaar-Kuijpers A., et al. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997. J Med Virol 66 2 (2002) 159-165
13. van Houdt R., Bruisten S.M., Koedijk F.D., Dukers N.H., Op de Coul E.L., Mostert M.C., et al. Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey. J Med Virol 79 7 (2007) 895-901
14. Koppelman M.H., and Zaaijer H.L. Diversity and origin of hepatitis B virus in Dutch blood donors. J Med Virol 73 1 (2004) 29-32
15. Boot H.J., Schouls L., Hahne S., Berbers G.A., van de Laar M., and Kimman T.G. Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme. Ned Tijdschr Geneeskd 151 3 (2007) 172-176
16. van Steenbergen J.E. Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners. J Hepatol 37 4 (2002) 507-513
17. van Houdt R., Sonder G.J., Dukers N.H., Bovee L.P., Van den Hoek A., Coutinho R.A., et al. Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands. Vaccine 25 14 (2007) 2698-2705
18. Xiridou M., Wallinga J., Dukers-Muijers N., and Coutinho R. Hepatitis B vaccination and changes in sexual risk behaviour among men who have sex with men in Amsterdam. Epidemiol Infect (2008) 1-9
19. Williams J.R., Nokes D.J., Medley G.F., and Anderson R.M. The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes. Epidemiol Infect 116 1 (1996) 71-89
20. de Wit GA, Kretzschmar M, van de Laar M. The cost-effectiveness of different vaccination strategies to prevent hepatitis B infection; in preparation.
21. Edmunds W.J., Medley G.F., Nokes D.J., Hall A.J., and Whittle H.C. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 253 1337 (1993) 197-201
22. Hahne S., Ramsay M., Balogun K., Edmunds W.J., and Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 29 4 (2004) 211-220
23. McMahon B.J., Alward W.L., Hall D.B., Heyward W.L., Bender T.R., Francis D.P., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 4 (1985) 599-603
24. Custer B., Sullivan S.D., Hazlet T.K., Iloeje U., Veenstra D.L., and Kowdley K.V. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38 10 Suppl. (2004) S158-S168
25. McMahon B.J., Bruden D.L., Petersen K.M., Bulkow L.R., Parkinson A.J., Nainan O., et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 142 5 (2005) 333-341
26. Johnson A.M., Wadsworth J., Wellings K., and Field J. Sexual attitudes and lifestyles (1994), Blackwell Scientific Publications, Oxford
27. de Wit J.B., Vet R., Schutten M., and van Steenbergen J. Social-cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men. Prev Med 40 6 (2005) 795-802
28. Baars J., Boon B., de Wit J.B., Schutten M., van Steenbergen J., Garretsen H., et al. Drug users' participation in a free hepatitis B vaccination program: demographic, behavioural and social-cognitive determinants. Subst Use Misuse; 43 14 (2008) 2145-2162
29. Edmunds W.J., Medley G.F., and Nokes D.J. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med 18 23 (1999) 3263-3282
30. Becker N.G., and Dietz K. The effect of household distribution on transmission and control of highly infectious diseases. Math Biosci 127 2 (1995) 207-219
31. Ball F., Britton T., and Lyne O. Stochastic multitype epidemics in a community of households: estimation and form of optimal vaccination schemes. Math Biosci 191 1 (2004) 19-40
32. Akmatov M.K., Kretzschmar M., Prüfer-Krämer L., and Krämer A. Screening and treatment of immigrants has highest impact on HBV carrier prevalence in Germany: results of a deterministic mathematical model. Eur J Public Health 18 1 (2008) 64
33. Kretzschmar M. Calculating and estimating the basic reproduction number of hepatitis B in a heterogeneous population. XXIst International Biometric Conference 2002. Freiburg, Germany (2002), International Biometric Society 175-186
34. Ramsay M., Gay N., Balogun K., and Collins M. Control of hepatitis B in the United Kingdom. Vaccine 16 Suppl. (1998) S52-S55